LAMOND DAVID purchased 2.6% of their position (57.37K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $58.1K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/7/2023ACC: 0001209191-23-057799
+57.37K
Net shares
Net buyer
$58.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
57.37K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+19.12K
Price / share
$1.01
Trade value
$19.31K
% of position
0.9%
12/5/2023
2.22M→2.24M
Common Stock
Indirect
Shares
+19.12K
Price / share
$1.02
Trade value
$19.51K
% of position
0.9%
12/6/2023
2.24M→2.26M
Common Stock
Indirect
Shares
+19.12K
Price / share
$1.01
Trade value
$19.31K
% of position
0.8%
12/7/2023
2.26M→2.28M
Total
Net shares
+57.37K
Net value
$58.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/5/2023 | P · Purchase | +19.12K | $1.01 | $19.31K | 0.9% | 2.22M | 2.24M |
| Common Stock Indirect | 12/6/2023 | P · Purchase | +19.12K | $1.02 | $19.51K | 0.9% | 2.24M | 2.26M |
| Common Stock Indirect | 12/7/2023 | P · Purchase | +19.12K | $1.01 | $19.31K | 0.8% | 2.26M | 2.28M |
| Total | +57.37K | $58.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned301.83K
Common Stock
IndirectShares owned1.73M
Total
301.83K direct·1.73M indirect2.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 301.83K | Direct |
| Common Stock | 1.73M | Indirect |
| Total | 2.04M | 301.83K direct·1.73M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported